MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation announces the Maxwell 16 DNA purification system is now CE marked in accordance with the requirements of Directive 98/79/EC IVD. The new mark particularly helps European clinical laboratories performing tests in molecular pathology and transplant HLA to achieve compliance with IVD directives in their countries. The new Maxwell 16 System supports DNA-based tests performed on blood and buffy-coat by clinical labs, including sample preparation for human transplantation donor-matching tests done in HLA labs. The system already meets the General Purpose Medical Device requirements in the United States.
